Early and Mid-Career Researchers' committee at the Monash Institute of Pharmaceutical Sciences
The early and mid-career researchers' committee at the Monash Institute of Pharmaceutical Sciences promotes specialised programs, exchange of scientific ideas and new collaborations for the benefit of researchers in the faculty of Pharmacy & Pharmaceutical Sciences. Each theme within MIPS has representatives on the committee who meet regularly to discuss needs, current issues and feedback of early and mid-career researchers.
The MIPS EMCR committee aims to:
- Provide support and assistance to researchers by organising specialised training programs and workshops.
- Organise networking events to provide an opportunity for multi-disciplinary collaborations across themes.
- Organise events focussed around research at MIPS and science outreach.
Ghizal completed her PhD with Professor Brian Cooke at Monash University, Clayton and her main research interest was to characterise a set of novel kinases unique to malaria parasites. Ghizal is currently doing her postdoctoral research in Darren Creek's laboratory and her main research interest has been to investigate the mechanisms of action and resistance for artemisinin antimalarials. In addition to this, Ghizal is the proteomics lead at MIPS for Monash Proteomics and Metabolomics Facility. Since 2016, Ghizal has been a member of the EMCR committee at MIPS and is the current president of the committee.
Anna Cifuentes Rius
Anna completed her PhD in Bioengineering at the Ramon Llull University in Barcelona, including a year’s stint at the Massachusetts Institute of Technology (MIT) and another one at the Australian Institute of Bioengineering and Nanotechnology (AIBN) at the University of Queensland (when she fell in love with Australia and Australian research). She works in the fields of nanomedicine and drug delivery and became part of the MIPS family in 2017. She joined the MIPS EMCR committee to drive and support gender equity and consumer engagement initiatives within the Faculty, which are two of her passions. You can find more about her interests on Twitter.
Greg completed his PhD in Molecular Pharmacology with Professors Arthur Christopoulos and Patrick Sexton through Monash University. He then moved to France to work in the laboratory of Dr Jean-Phillipe Pin on understanding GABAb receptor complexes and post-translational modifications. He then returned to MIPS to take up a position with Dr Chris Langmead in collaboration with a pharmaceutical company, Servier. He is currently the project leader for Translational Neuroscience within the Langmead group, which specialises in CNS orphan GPCRs and their role in psychiatric disorders.
Giri completed his PhD from The University of Queensland in Medicinal and biomolecular chemistry. He joined monash university in Feb 2017 and His current research focused on the biased formyl peptide receptor (FPR) agonists for the treatment of myocardial infarction. He is currently involved in the Grants and Professional Development programs at the MIPS EMCR committee and is the current Treasurer.
Arisbel Batista Gondin
Outreach and Marketing lead
Arisbel completed a joint PhD program in Molecular Pharmacology and Drug Discovery in March 2019 at Monash University and The University of Nottingham (UK). As a postdoctoral researcher, she is now establishing technologies at MIPS for the development of single-domain antibodies (nanobodies). Nanobodies are extremely versatile tools that have proven to be useful in many research areas including structural biology, drug delivery and as biosensors for imaging. She joined the MIPS EMCR committee to drive and support gender equity initiatives. She is also passionate about science communication and outreach. You can find more about her on Twitter.
Andy completed his PhD in fluorescent-based sensors for explosives detection at the Centre for Organic Photonics & Electronics at the University of Queensland. His subsequent research has focussed on the use of neutron and X-ray scattering techniques to unearth structure-function relationships in applied organic materials systems and he is currently an ARC DECRA fellow at MIPS investigating the influence of lipid digestion on molecular self-assembly and absorption of bioactives in the gut. Around a third of Parkville-based staff are parents and facilitating child care initiatives for the Parkville community is a key issue for EMCRs in particular. Being a young father, Andy volunteered to act as the committee's point of contact for parental matters. He has put together a guide to finding child care in Australia to support new researchers joining the Monash Parkville community. The guide can be downloaded from here. Andy also runs the Parkville Parent’s Group, which holds monthly meetings during which Parkville-based parents can support one another by sharing their experiences and providing a forum for free discussion on all things parental (free coffee provided). If you are interested in the parent’s group, the guide to finding child care, or simply talking through parental issues, please contact Andrew by any of the following channels:
Phone: +61 3990 39720
Anubhav completed his PhD from the University of Glasgow, UK in biochemistry and molecular biology and joined the pharmaceutical metabolomics laboratory at MIPS for his postdoctoral work. His current areas of interest are high-throughput detection of cancer biomarkers and discovering new drug targets for treating infectious diseases using CRISPR Cas-9 and analytical chemistry.
Ximo completed his PhD in Organic and Supramolecular Chemistry at the University of Valencia in Spain. His research focusses on Polymer Therapeutics (design of nanomaterials that can deliver therapeutic drugs directly to a disease site). He joined the EMCR committee to put into practice some of his ideas to unite and facilitate networking between other EMCRs. For him, multidisciplinary interaction and communication is essential to generate creative ideas. He teaches Spanish to EMCRs to facilitate a friendly networking environment. He is a big fan of colourful Trello boards and has introduced them to the committee.
Jenni is a pharmacist with a PhD in alcohol epidemiology from the University of Eastern Finland. During her PhD Jenni published the first application of a marginal structural model in alcohol epidemiology.
Simon is a postdoctoral fellow currently utilising electrophysiology and behavioural pharmacology to understand how targeting CNS muscarinic receptors could be used to increase symptom coverage in schizophrenia. He is also interested in the physiological underpinnings of cognition more generally. Simon’s PhD focused on utilising a metal delivery approach to improve the behavioural and biochemical phenotype of multiple models of neurodegeneration. He is passionate about integrity, ethics, diversity, and transparency in science. Simon is also passionate about science communication and is currently secretary of the Australian science communicator society (Victoria)